📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia. (2025)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.adr1476

PubMed Identifier: 40238916

Publication URI: http://europepmc.org/abstract/MED/40238916

Type: Journal Article/Review

Volume: 17

Parent Publication: Science translational medicine

Issue: 794

ISSN: 1946-6234